NanoViricides Inc (NNVC)

[Ovidius]

Well, the same hype has been going around for years.
Given the 'mixed' results of late, somewhat significant for dengue and lukewarm for Ebola, how does Dr. F see that NNVC will capture the whole market for these viruses? Aside from the hundreds of other companies doing research in the same fields, there is no indication from the recent mentioned results that NNVC will be any better than other products.
The only place where we have seen 99% success rates, is in company PRs and not from independents.

Of course, there is the issue of 30% of all profits being given directly to Dr. D before the shareholders get anything.
In fact, a lawyer who specializes in corporate law who looked over all the legal documents available on line for NNVC, commented to me that it had a structure that was insider biased and shareholder unfriendly, FYI.

Even the herpes cream seems to have slipped into a wormhole outside of space and time. And of course there is the gap in the Japan pink eye deal that fell apart for suspicious reasons, another promise of a big pharma deal that went no where.

And the Jan 2009 'secret' big pharma deal whose deadline is up or approaching and no news or deals announced.

So, how about a little realism added to these $5.00 a share projections.